Effects of recombinant human erythropoietin (rHuEPO) therapy on exercise capacity and quality of life in patients with end-stage renal failure.

KIDNEY INTERNATIONAL(1998)

Cited 0|Views4
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined